.jpg)
.jpg)
.jpg)
Recommended
May 13, 2025
Over 70,000 Eye Products Recalled in USA After FDA Audit
A voluntary nationwide recall of multiple ophthalmic products was issued on May 12, citing potential safety concerns stemming from serious manufacturing violations.
Breaking News
Intalight Secures CE Mark for DREAM OCT Platform, Clears Path for Commercialization in Europe
May 16, 2025
Intalight has announced that it has received CE Mark approval for its next-generation DREAM OCT platform, authorizing the commercialization of the technology across the European Union
Over 70,000 Eye Products Recalled in USA After FDA Audit
May 13, 2025
A voluntary nationwide recall of multiple ophthalmic products was issued on May 12, citing potential safety concerns stemming from serious manufacturing violations.
FDA Grants Clearance for OcuMet Beacon Retinal Imaging Device
May 06, 2025
OcuSciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted regulatory clearance for its flagship diagnostic device, the OcuMet Beacon.
.jpg)
Industry News
Nicox Reports Positive Results from Whistler Phase 3b Trial of NCX 470 in IOP Reduction
May 16, 2025
Nicox has announced results from the Whistler Phase 3b exploratory trial, evaluating the intraocular pressure (IOP)-lowering effects of NCX 470 ophthalmic solution 0.1% in both healthy volunteers and patients with ocular hypertension.
Bausch + Lomb Launches Zenlens CHROMA HOA Scleral Lens in the U.S.
May 15, 2025
Bausch + Lomb has officially launched Zenlens CHROMA HOA in the United States—a custom, wavefront-guided scleral contact lens specifically designed to correct higher-order aberrations (HOA).
Oral Zervimesine Slows Geographic Atrophy Progression in Phase 2 Dry AMD Trial
May 14, 2025
Cognition Therapeutics has announced topline results from its Phase 2 Magnify study, evaluating the oral drug zervimesine in patients with geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD).
Ophthalmic Research News
Mild Intraocular Inflammation More Frequent with Aflibercept 8 mg in Real-World Use, Study Finds
May 16, 2025
A new study published in JAMA Ophthalmology reports a higher real-world incidence of mild intraocular inflammation (IOI) following intravitreal injections of aflibercept 8 mg compared to rates observed in clinical trials.
Aqueous Humor Liquid Biopsy Proven Safe in Pediatric Retinoblastoma Patients
May 15, 2025
A study confirms that aqueous humor liquid biopsy, performed via anterior chamber paracentesis, is a safe and well-tolerated procedure for pediatric patients diagnosed with retinoblastoma or retinoblastoma-simulating lesions.
Elevated Intraocular Pressure Linked to Vision Loss and Optic Nerve Damage, Study Finds
May 15, 2025
Elevated eye pressure (ocular hypertension) may play a more direct role in irreversible vision loss than previously understood, according to a study published in Ophthalmology Science.
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe